Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations.
about
The Obesity-Breast Cancer Conundrum: An Analysis of the IssuesExercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and ProgressionThe Interactions of Obesity, Inflammation and Insulin Resistance in Breast CancerObesity and cancer: mechanistic insights from transdisciplinary studiesBody Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast CancerFavorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data?Efficacy and Mechanisms of Aerobic Exercise on Cancer Initiation, Progression, and Metastasis: A Critical Systematic Review of In Vivo Preclinical DataWeight control and cancer preventive mechanisms: role of insulin growth factor-1-mediated signaling pathwaysRisk of breast cancer recurrence associated with carbohydrate intake and tissue expression of IGFI receptorHyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer.Metabolic syndrome in breast cancer.Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial.Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis.Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study.Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study.Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant StressImpact of Weight Loss on Plasma Leptin and Adiponectin in Overweight-to-Obese Post Menopausal Breast Cancer SurvivorsEffect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32.The role of obesity in cancer survival and recurrence.Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy.Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial.Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality.Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adultsRisk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening.Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer.Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831.Breast cancer survivorship symptom management: current perspective and future development.The presentation of metabolic dysfunction and the relationship with energy output in breast cancer survivors: a cross-sectional studyThe predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.Potential applications for biguanides in oncologyLeptin receptor maintains cancer stem-like properties in triple negative breast cancer cells.Prognostic value of glycated hemoglobin in colorectal cancer.The association between adiposity and breast cancer recurrence and survival: A review of the recent literatureBody mass and smoking are modifiable risk factors for recurrent bladder cancer.Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progressionFavorable effects of low-fat and low-carbohydrate dietary patterns on serum leptin, but not adiponectin, among overweight and obese premenopausal women: a randomized trial.Adipokine leptin in obesity-related pathology of breast cancer.Biochemical and molecular mechanisms for the association between obesity, chronic inflammation, and breast cancer.Insulin and IGFs in obesity-related breast cancer.
P2860
Q26747486-49CC96AB-85E9-4326-B846-51B1C2C02C5CQ26775189-BA31A8CE-32B7-4953-8E2B-96D47341DDBEQ26777775-DE04AEF4-E942-4F2A-BE75-7A1187A390FAQ26786829-7CF2A785-EFC1-4535-BEF8-064F1DD13074Q28109681-968AB62A-15CE-4B6F-99A5-49AC7D6CA098Q30409720-65BC193C-0411-4352-8F40-32CA2F56588CQ30572730-03866AC2-9059-438B-ADC1-B511A660FC97Q31112729-AD4BF2AF-3B20-4BDF-BB27-FF5E1594B393Q33724772-86E0E544-1AD9-4263-BC2E-9B4DD6C0EDB0Q33847983-E82A8D17-7575-4CEE-BF08-B0113344CD46Q33887610-1B340AB2-6971-44F4-8AFB-D9BD4E11B78AQ33973037-28E9677C-B089-4C10-B62A-7298F3A271ABQ34334262-296E10E8-964D-4D1D-A179-F6B3610B18F9Q34649283-DBD07951-1D66-4B83-9462-A68CFF09C852Q34660089-C0DF7D80-E98D-460D-97C2-CBE2382B09A4Q35678685-66924160-365F-46A5-912D-CE5B44112B7FQ35782187-B5749A95-0B46-4FE2-A41A-7DC44356A936Q35894947-4890A2D8-A670-4AD2-A89A-A261DE9FA010Q36047450-29927101-CCF5-47CB-9068-75BF750630D7Q36152955-10E71DC8-E370-49B1-A0F2-E133CC308BCEQ36210178-9B647B51-D19A-4709-8CB2-6305ABD6C6ACQ36368902-568A292D-4C46-4FED-9808-E5A14EE11DD9Q36438347-7924F2DF-A6D4-4CA9-AAD9-B6189BF9CC21Q36519849-1EE692F4-E51D-48FC-B3CA-4545456B5A92Q36831817-A573B3D7-0835-4A91-8AD9-E2F811B52E67Q36863215-D563B2FF-41C6-4009-AECC-85115AF845A7Q36941405-66791ABC-AA2B-4DE6-B402-DFFC5EAD5BC5Q36956837-1436B550-B52A-4709-B246-F1414B396283Q37029323-D7F44870-0079-48D8-AC72-F439363E31C1Q37081862-79059B46-2185-426E-B5C8-A503617D2868Q37123877-6869D3E2-132E-4D7A-A5B5-2002306656EEQ37350862-E52CF108-FC8F-464E-8C4A-C1ED1AAAA219Q37483467-D7771FA3-8AC3-4571-9136-F56B23A6E148Q37579337-4EB20098-3933-492D-ACF3-005C21BE944AQ37625336-2DAC52D5-780B-46CA-990A-3DA4FB831881Q37690552-B7D05F50-54AB-48E8-B23B-B11808DD670AQ37724421-1BF45414-A1E0-4384-87B5-229BD3E6841AQ38009725-02E6DF70-DD71-4F64-A29B-8D41C7D2E1EFQ38121858-0171849A-CB86-4C9E-A2D8-B24486396CC5Q38155073-F4DBDDFD-57E9-4D4B-9EE3-9565C1972160
P2860
Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Insulin- and obesity-related v ...... se of prognostic associations.
@en
Insulin- and obesity-related v ...... se of prognostic associations.
@nl
type
label
Insulin- and obesity-related v ...... se of prognostic associations.
@en
Insulin- and obesity-related v ...... se of prognostic associations.
@nl
prefLabel
Insulin- and obesity-related v ...... se of prognostic associations.
@en
Insulin- and obesity-related v ...... se of prognostic associations.
@nl
P2093
P356
P1476
Insulin- and obesity-related v ...... se of prognostic associations.
@en
P2093
Jarley Koo
Marguerite Ennis
Maureen E Trudeau
Nicky Hood
Sara K Taylor
P304
P356
10.1200/JCO.2011.36.2723
P407
P577
2011-12-12T00:00:00Z